J. P. A. Baak

1.3k citations

27 papers · 1.1k indexed · h-index 17

Oncology top 5%
Molecular Biology
Pulmonary and Respiratory Medicine top 10%
Surgery
Pediatrics, Perinatology and Child Health top 10%

Co-authors: P. J. van Diest G Brugal J. Lankelma C.M. Kuiper H. M. Pinedo Andrés Cervantes John H. Lange J. F. M. Delemarre
Topics: Drug Transport and Resistance Mechanisms (5 papers)Ovarian cancer diagnosis and treatment (5 papers)Pregnancy and preeclampsia studies (4 papers)
Cited by: Oncology Reproductive Medicine Obstetrics and Gynecology
Journals: Gastroenterology JNCI Journal of the National Cancer Institute British Journal of Cancer
Partner nations: Netherlands France Poland

In The Last Decade

J. P. A. Baak

27 papers receiving 1.0k citations

Peers

Countries citing papers authored by J. P. A. Baak

Since Specialization

Citations

This map shows the geographic impact of J. P. A. Baak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. A. Baak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. A. Baak more than expected).

Fields of papers citing papers by J. P. A. Baak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. A. Baak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. A. Baak. The network helps show where J. P. A. Baak may publish in the future.

Co-authorship network of co-authors of J. P. A. Baak

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. A. Baak. A scholar is included among the top collaborators of J. P. A. Baak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. A. Baak. J. P. A. Baak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proliferation markers in tumours: interpretation and clinical value. 1998 ·Journal of Clinical Pathology ·P. J. van Diest,G Brugal,J. P. A. Baak	181
2	Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation 1998 ·The Journal of Pathology ·Wojciech Polkowski,J. P. A. Baak,J.J.B. van Lanschot,Gerrit A. Meijer,(unknown),F. J. W. ten Kate,H Obertop,G. J. A. Offerhaus	7
3	Counting mitoses by image processing in Feulgen stained breast cancer sections: The influence of resolution 1997 ·Cytometry ·Jeroen A.M. Beliën,J. P. A. Baak,P. J. van Diest,(unknown)	2
4	Placenta morphology and absent or reversed end diastolic flow velocities in the umbilical artery: a clinical and morphometrical study 1996 ·Placenta ·V.H.M. Karsdorp,B. Dirks,J.C. van der Linden,J. M. G. van Vugt,J. P. A. Baak,Herman P. van Geijn	21
5	Peripheral primitive neuroectodermal tumour and extra-osseous Ewing's sarcoma; a histological, immunohistochemical and DNA flow cytometric study 1995 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Mariël Brinkhuis,Liliane C. D. Wijnaendts,J.C. van der Linden,J. P. A. Baak,Chris J.L.M. Meijer,A. J. M. van Unnik,P.A. Voûte	34
6	Prognostic relevance of P-glycoprotein expression in breast cancer 1995 ·Annals of Oncology ·S. C. Linn,Giuseppe Giaccone,P. J. van Diest,(unknown),Paul van der Valk,C.K. van Kalken,C.M. Kuiper,Herbert M. Pinedo,J. P. A. Baak	73
7	p53 and Ki67 as markers for tumor progression in the Barrett's metaplasia-dysplasia-carcinoma sequence 1995 ·Gastroenterology ·Wojciech Polkowski,JJB van Lanschot,(unknown),J. P. A. Baak,(unknown),H. Obertop,(unknown)	5
8	The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence 1995 ·Surgical Oncology ·Wojciech Polkowski,J. Jan B. van Lanschot,F.J.W. ten Kate,J. P. A. Baak,G. N. J. Tytgat,H. Obertop,(unknown),G. Johan A. Offerhaus	76
9	Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. 1995 ·PubMed ·G.J. Schuurhuis,H J Broxterman,GJ Ossenkoppele,J. P. A. Baak,CA Eekman,C.M. Kuiper,N Feller,(unknown),E. Klumper,Rob Pieters	72
10	Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells 1993 ·British Journal of Cancer ·GJ Schuurhuis,(unknown),Andrés Cervantes,HM Pinedo,(unknown),(unknown),H J Broxterman,J. P. A. Baak,J. Lankelma	55
11	An expert system for histological typing and grading of invasive breast cancer 1992 ·Pathology - Research and Practice ·P. J. van Diest,Jeroen A.M. Beliën,J. P. A. Baak	7
12	Quantification by laser scan microscopy of intracellular doxorubicin distribution 1992 ·Cytometry ·John H. Lange,N W Schipper,G.J. Schuurhuis,(unknown),(unknown),Herbert M. Pinedo,J. Lankelma,J. P. A. Baak	46
13	Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein 1991 ·British Journal of Cancer ·GJ Schuurhuis,HJ Broxterman,(unknown),H. M. Pinedo,(unknown),C.M. Kuiper,(unknown),RJ Scheper,(unknown),J. P. A. Baak,J. Lankelma	93
14	Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant Cells 1989 ·JNCI Journal of the National Cancer Institute ·Gerrit Jan Schuurhuis,Henricus J. Broxterman,Andrés Cervantes,(unknown),John H. Lange,J. P. A. Baak,H. M. Pinedo,J. Lankelma	92
15	Second primary lung cancer: importance of long term follow up. 1989 ·Thorax ·Peter C. Van Bodegom,Sjoerd Sc. Wagenaar,B Corrin,J. P. A. Baak,J. Berkel,R.G.J.R.A. Vanderschueren	83
16	Possibilities and progress of quantitative pathological examination of ovarian tumours 1988 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·J. P. A. Baak	3
17	The prognostic value of morphometrical features and cellular DNA content in cis-platin treated late ovarian cancer patients 1988 ·British Journal of Cancer ·J. P. A. Baak,(unknown),(unknown),(unknown),(unknown),(unknown),J. Wils	50
18	Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing. 1986 ·PubMed ·J. P. A. Baak,F. A. Langley,A. Talerman,J. F. M. Delemarre	48
19	Grading ovarian tumors. Evaluation of decision making by different pathologists. 1986 ·PubMed ·J. P. A. Baak,J. F. M. Delemarre,F. A. Langley,A. Talerman	17
20	Quantitative morphology of the placenta II. The growth of the placenta and the problem of postmaturity 1978 ·European Journal of Obstetrics & Gynecology and Reproductive Biology ·(unknown),L.A.M. Stolte,J. P. A. Baak,J. H. Oort	18

About J. P. A. Baak

J. P. A. Baak is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (5 papers), Ovarian cancer diagnosis and treatment (5 papers) and Pregnancy and preeclampsia studies (4 papers). The work is most often cited by research in Oncology (509 citations), Reproductive Medicine (105 citations) and Obstetrics and Gynecology (95 citations). J. P. A. Baak has collaborated with scholars based in Netherlands, France and Poland. Frequent co-authors include P. J. van Diest, G Brugal, J. Lankelma, C.M. Kuiper, H. M. Pinedo, Andrés Cervantes, John H. Lange, J. F. M. Delemarre, F. A. Langley and A. Talerman. Their work appears in journals such as Gastroenterology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact